Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2010
06/17/2010US20100150842 Method and Kit for Detecting Resistance in Living Organisms
06/17/2010CA2746251A1 Composition comprising isoflavones
06/17/2010CA2745970A1 Dihydropyrimidopyrimidine derivative
06/17/2010CA2745959A1 Dihydropyrimidopyrimidine derivatives
06/16/2010EP2196930A1 Cavity induced allosteric modificatin of intermolecular interactions and methods of identifiying compounds that effect the same
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2196220A1 Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
06/16/2010EP2196205A1 Topoisomerase poisons
06/16/2010EP2194988A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
06/16/2010EP1645566B1 Analogs of parathyroid hormone
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010EP1364010B1 Immunomodulatory polynucleotides and methods of using the same
06/16/2010EP1349857B1 Purine derivatives as purinergic receptor antagonists
06/16/2010CN1951376B Novel medical usage of protocatechualdehyde
06/16/2010CN1886141B T-type calcium channel inhibitor
06/16/2010CN1863543B Dietetic composition
06/16/2010CN1822822B Saquinavir mesylate oral dosage form
06/16/2010CN1771040B Remedy for diabetes.
06/16/2010CN1635864B Oligosaccharide aldonic acids and their topical use
06/16/2010CN1596103B Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
06/16/2010CN1543338B Chitin microparticles and their medical uses
06/16/2010CN101735951A Micro-ecological composite bacterium preparation used for aquatic products and preparation method thereof
06/16/2010CN101735131A New salts
06/16/2010CN101732622A Chinese medicament for treating ischidrosis
06/16/2010CN101732617A Ointment for treating neonatal pathological jaundice
06/16/2010CN101732582A Five organ reconciling powder
06/16/2010CN101732467A Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy
06/16/2010CN101732314A Composition of naloxone hydrochloride and polyvinylpyrrolidone and preparation method thereof
06/16/2010CN101732313A Medicine composition of naloxone hydrochloride and polyethylene glycol and preparation method thereof
06/16/2010CN101732298A Treating benign prostate hyperplasia with sarms
06/16/2010CN101732287A Injection of mannite and glycerol and preparation method thereof
06/16/2010CN101322845B Erianin inclusion compound
06/16/2010CN101259118B Application of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone as PPAR gamma agonist
06/16/2010CN101189997B Notoginseng flower brain tonic tea
06/16/2010CN101045161B Modulators of P-selectin glycoprotein ligand 1
06/16/2010CN101002625B Beverage for relieving summer heat, and its preparing process
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737264 Oligomeric compounds for the modulation HIF-1α expression
06/15/2010US7737258 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/15/2010US7737162 Viral inhibitors
06/15/2010US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
06/15/2010US7737118 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time
06/15/2010US7736899 Cells and method for producing proteins comprising an unconventional amino acid
06/15/2010US7736895 Altering differentiated state of somatic cells via adjusting gene expression patterns; removing suppressor protein from chromatin masses; reprogramming differentiated cells
06/15/2010US7736678 Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery
06/15/2010US7736675 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and/or a chitosan derivative and an antioxidant such as vitamin C and vitamin E
06/15/2010US7736655 Neuroprotectants; angoigenesis inhibitors; transcription factors; host cells
06/15/2010US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy
06/15/2010US7735485 Dry powder inhalation system for transpulmonary administration
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/15/2010CA2430518C Guanidine and amidine derivatives as factor xa inhibitors
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/15/2010CA2402609C Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/15/2010CA2320288C Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/10/2010WO2010065755A1 Deuterated pyridinones
06/10/2010WO2010064736A1 Therapeutic agent for cancer
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064705A1 Novel 7-substituted dihydropyranopyrimidine derivative having h4 receptor antagonistic activity
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064611A1 Heterocyclic compound and use thereof
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064422A1 Method for killing tumor by photosensitization treatment under conditions where histone is highly acetylated
06/10/2010WO2010064373A1 Il-8 inhibitor and process for producing same
06/10/2010WO2010011349A3 Pyrimidine-2,4-diamines as jak2 kinase inhibitors for treatment of inflammation
06/10/2010WO2010004054A3 Nucleic acid comprising zwitterionic nucleotides
06/10/2010US20100146662 Use of r-genes as a selection marker in plant transformation and use of cisgenes in plant transformation
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100144899 Method for preparing nano-emulsions
06/10/2010US20100144894 Use of dicalcium phosphate anhydride powder
06/10/2010US20100144866 Anti-fatigue agents and oral compositions containing andrographolide as active ingredient
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144724 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144661 Sodium channel blockers
06/10/2010US20100144660 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer thereapy
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144612 Phosphorylated pyrone analogs and methods
06/10/2010US20100144597 Novel combinatorial approaches to enhancing oxygen transport to tissues
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010US20100144039 Pluripotency determining factors and uses thereof
06/10/2010US20100143481 Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
06/10/2010US20100143479 Method of making sustained release microparticles
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143443 Biological artificial ligament and method of making
06/10/2010US20100143435 Scaffold with increased pore size
06/10/2010US20100143434 Mechanically responsive supported polyelectrolyte multilayer films
06/10/2010US20100143362 LINGO binding molecules and Pharmaceutical Use Thereof
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 1564